Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?



Rexahn Pharmaceuticals (RNN) Continues to Spike on Potential Cancer Pill, Roth Upgrade

By  +Follow January 13, 2014 10:17AM
Tickers Mentioned:

Shares in Rexahn Pharmaceuticals (RNN) jumped nearly 40 percent on Monday, continuing a bull-run that has the stock up over 150 percent since Thursday and over 265 percent in the last month on a promising potential cancer treatment and the initiation of relatively bullish coverage from Roth Capital Markets analysts.

RNN’s RX-3117 Could be Alternative for Eli Lilly’s Gemzar

Driving the current growth-spurt is the announcement of the initation of Phase 1b to study the safety and efficacy of RX-3117, Rexahn’s lead drug candidate, in cancer patients with solid tumors. The hype surrounding RX-3117 is considerable given that it has to potential to function as an oral to Eli Lilly’s (LLY) Gemzar.

"The initiation of this Phase I clinical trial of RX-3117 represents an important milestone for Rexahn," said CEO Peter D. Suzdak, Ph.D. "This compound is exciting to work with, as it has a unique profile with demonstrated activity against gemcitabine-resistant human cancer cells. We were pleased to see reduced side effect liability and oral bioavailability in cancer patients in our initial exploratory Phase I clinical trial conducted in Europe, and we believe that RX-3117 may represent a significant advancement in the treatment of cancer patients with solid tumors."

Gemzar is an injectable drug that results in resistance for 1 out of 4 patients, making an alternative that functions in pill form one with considerable commercial potential.

Analyst Seems Convinced

Also helping boost shares over the past few days was the news from Thursday that Roth Capital Markets’ Joe Pantiginis had initiated coverage on the stock at a “buy” rating with a price target of $3, still nearly double the current share price even after the spike in price.

Along with the considerable potential for RX-3117, the company boasts nearly $15 million in cash as well as over $5 million in new funding, giving it enough money to carry it for two years.


DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for rnn
Bilo Selhi
26 Nov 15 09:56:07
Need help finding momentum trades? https://t.co/uAcamNRUPt https://t.co/8E0ttuzc9u $IVOB $OHGI $CASM $OCLR $RNN $SGTPY $VMEM $NTLS $HMY
Dakota Financial
26 Nov 15 09:54:46
Analysts Anticipate Rexahn Pharmaceuticals to Post $$0.03 Earnings Per Share $RNN https://t.co/aC3mQzEpit
Consumer News
26 Nov 15 09:51:29
Analysts Anticipate Rexahn Pharmaceuticals to Post $$0.03 Earnings Per Share $RNN https://t.co/R7CTnXjQn0 #acn
Ticker Report
26 Nov 15 09:50:32
Analysts Anticipate Rexahn Pharmaceuticals to Post $$0.03 Earnings Per Share $RNN https://t.co/ZqoUJ8gnkf
26 Nov 15 09:50:10
$RNN: Analysts Anticipate Rexahn Pharmaceuticals to Post ($0.03 …: https://t.co/0oP97JPmOm
US Banking News
26 Nov 15 09:48:36
Analysts Anticipate Rexahn Pharmaceuticals to Post $$0.03 Earnings Per Share $RNN https://t.co/cKt6wSpQsb
25 Nov 15 23:36:26
Rexahn Pharmaceuticals Short Interest Up 0.3% in November $RNN https://t.co/b0WzgGtW9B
25 Nov 15 23:27:08
$RNN: Rexahn Pharmaceuticals Short Interest Up 0.3% in November (RNN): https://t.co/dKMYebbakT
Dakota Financial
25 Nov 15 23:07:54
Rexahn Pharmaceuticals Sees Large Increase in Short Interest $RNN https://t.co/ySKU0fufCm
Consumer News
25 Nov 15 23:04:34
Rexahn Pharmaceuticals Sees Large Increase in Short Interest $RNN https://t.co/m7tFx90hsS #acn
Ticker Report
25 Nov 15 23:03:25
Rexahn Pharmaceuticals Sees Large Increase in Short Interest $RNN https://t.co/RReg9vwpdM
US Banking News
25 Nov 15 23:01:33
Rexahn Pharmaceuticals Sees Large Increase in Short Interest $RNN https://t.co/GxXlJG8W4u
US Banking News
25 Nov 15 23:00:13
$RNN - Rexahn Pharmaceuticals Sees Large Increase in Short Interest #RNN https://t.co/9uZU0v7gfo
Breaking News Now
25 Nov 15 22:59:10
$RNN: Rexahn Pharmaceuticals Sees Large Increase in Short Interest (RNN): https://t.co/YA8uGDffgq
25 Nov 15 06:25:16
RT @FrozenTraders: $RNN Unusual volume PM
Ron Campbell
25 Nov 15 06:00:43
$RNN Unusual volume PM
25 Nov 15 05:52:10
@beach_trades $RNN some am volume
24 Nov 15 13:46:03
$RNN: Wall Street analysts bullish on RNN's earnings growth: https://t.co/lmmaJUZObH https://t.co/nbHDpF0cpE
24 Nov 15 08:49:43
$SNTA and $RNN .44 #ReggieMe
Hot Stocks&Biotechs
24 Nov 15 04:35:58
RT @mrktmastr: $RNN $PPCH https://t.co/CJxg94LFKX
Eric Johnson
24 Nov 15 03:48:16
$RNN $PPCH https://t.co/CJxg94LFKX
Pamela Backer
24 Nov 15 02:32:47
$SNGX is a undervalued GEM $INO $TKMR $CTIC $CTIX $CELS $ATRS $CPRX $GALE $KBIO $RNN $GILD $ISIS https://t.co/obSooxMn59
Lena Dodson
24 Nov 15 01:40:42
CRIMINAL GUYS SHORTING the WORLD now they PAY $KBIO and more $BLRX $INO $ATRS $INO $CPRX $RNN and much more
23 Nov 15 17:45:58
@BioInvestor2013 https://t.co/P9q1HZGD0V $KBIO $BLRX $ISIS $GILD $TEVA $MERK $NVS $PFE $INO $RNN $CTIX $CTIC $DNDN $WMBO
Momz Day Trading
23 Nov 15 12:32:36
Love $RNN
Edwin Claudio
23 Nov 15 10:54:41
$RNN this could be the next KBIO or AVXP one day..buy buy buy
23 Nov 15 08:34:11
$RNN $CNBKA: Hot Alert: Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN …: https://t.co/2HtzNWMTga
23 Nov 15 07:48:55
$SNGX is a undervalued GEM $INO $TKMR $CTIC $CTIX $CELS $ATRS $CPRX $GALE $KBIO $RNN $GILD $ISIS https://t.co/38vcQONl2d
23 Nov 15 07:43:38
Want automatic email alerts for $CWT $SLH $OMCM $IMMY $RNN? Subscribe to MarketBeat Daily https://t.co/nSJuDsYidj
Reporting Standards
21 Nov 15 18:07:59
$rnn REXAHN PHARMACEUTICALS, INC. filed a new #XBRL report to the #SEC. https://t.co/AzwH26UaGR
21 Nov 15 02:49:03
USO United States Oil Fund, LP Financials https://t.co/5xUQtzaKUk $USO $GKN.L $DNO $RNN #USO #invest #invest
21 Nov 15 02:48:33
UGA United States Gasoline Fund, LP P/E Ratio https://t.co/7RylU2T2hK $UGA $SBUX $RNN $CMG #UGA #invest #invest
21 Nov 15 02:46:05
RNN Rexahn Pharmaceuticals, Inc. Open https://t.co/11cT1WmLZE $RNN $GDXJ $VRX $DVAX #RNN #share #stocks
21 Nov 15 02:42:33
MTCH Match Group, Inc Summary https://t.co/deCMd2RrYQ $MTCH $RNN $DIA $LQD #MTCH #tradeideas #finance
21 Nov 15 02:36:32
DIS Walt Disney Co. Filings https://t.co/irVSSyl3Ee $DIS $RNN $CRMT $GGG.V #DIS #share #pennystocks
21 Nov 15 02:35:05
CHD Church & Dwight Co, Inc. Yield https://t.co/cPpvQriL6F $CHD $JNPR $EXEL $RNN #CHD #pennystocks #nasdaq
19 Nov 15 06:50:09
JBEM new pick 'PIRS'.Read here: https://t.co/vD9rNW2f06 $ISIS $LIVN $PDEX $RNN $CYAN $ROX
18 Nov 15 20:16:02
JBEM new pick 'PIRS'.Read here: https://t.co/vD9rNW2f06 $RNET $RNF $RNG $RNN $RNO $RNP $RNR $RNR-C
Julia Romanov
18 Nov 15 07:50:34
@Imkingjon King Jonathan: $RNN told you guys to get out and move on. You only have until April for ... https://t.co/KTaF8oT9Z0 #freemoney
King Jonathan
18 Nov 15 07:44:33
$RNN told you guys to get out and move on. You only have until April for another correction. #makemoney
By  +Follow January 13, 2014 10:17AM



blog comments powered by Disqus

 Today's Must Reads

What Crowdfunding Leaders Are Saying About the SEC’s Approval of Title III

How the Drug Price Scrutiny is Affecting Pharma Stocks

8 More Tips for Choosing the Right Crowdfunding Platform

Will the Post-Smartphone Era Bring Wearable Drones?

3 Cloud Stocks That Pay Dividends


Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register